Antimalarial Drug Research and Development ( Pharmacology - Research, Safety Testing and Regulation )

Publication series :Pharmacology - Research, Safety Testing and Regulation

Author: Antoine C. Banet and Philippe E. Brasier  

Publisher: Nova Science Publishers, Inc.‎

Publication year: 2013

E-ISBN: 9781629482095

Subject: R531.3 Malaria

Keyword: Pharmacology

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Malaria-like febrile illnesses have been described since Hippocrates as fevers that were periodic and associated with marshes and swamps. The word malaria comes from the Italian malaria for bad airs. Malaria is transmitted to humans via the bite of the infected female mosquito of anopheles species. Malaria can exist, in a mild form that is most commonly associated with flu-like symptoms; fever, vomiting, and general malaise. Most disease cases are found in the poorest countries; tropical Africa, Latin America, Southern Asia and Oceania. More concern is being given now to malaria even in countries where there is a low risk of infection due to the phenomena of global warming which is significantly increasing. In this book, the authors present current research in the study of antimalarial drug research and developments. Topics discussed in this compilation includ the antimalarial atovaquone prodrugs based on enzyme models with molecular orbital calculations approach; new quinoline-based multiple ligands in antimalarial drug development; new molecular scaffolds as potential therapeutic agents to combat antimalarial resistance; and PfCRT mediates sensitivity of chloroquine-resistant P. Falciparum to diamidines.

The users who browse this book also browse